Abingdon Health 8.00p £15.49m (ABDX.L)
The international lateral flow contract research and contract development and manufacturing organisation (CDMO), reports winning a £0.5m 12-month contract. Starting in March 2025, its recently acquired subsidiary, CS (Lifesciences) Ltd, will work with a major global diagnostics client on quality management systems and regulatory approvals. The CS subsidiary is a consultancy specialising in compliance requirement in international in vitro diagnostics and m ....
08 Jan 2025
Small Cap Feast
PYC Therapeutics Limited (PYC:ASX), 0 | Mirriad Advertising plc (MIRI:LON), 0.0 | ProCook Group PLC (PROC:LON), 36.4 | 029 Group SE (Z29:ETR), 0 | 1895 Bancorp of Wisconsin Inc (BCOW:NYSE), 0 | 1895 Bancorp of Wisconsin Inc (BCOW:OTC), 0 | Coral Products plc (CRU:LON), 8.6 | Cordel Group PLC (CRDL:LON), 6.2 | Diaceutics Plc (DXRX:LON), 142 | Guardian Metal Resources PLC (GMET:LON), 158 | HemoGenyx Pharmaceuticals Plc (HEMO:LON), 636 | 10X Genomics Inc (TXG:NYSE), 0 | 10x Genomics Inc Class A (TXG:NAS), 0 | 123fahrschule SE (123F:ETR), 0 | Abingdon Health PLC (ABDX:LON), 6.5
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Small Cap Feast
PYC Therapeutics Limited (PYC:ASX), 0 | Mirriad Advertising plc (MIRI:LON), 0.0 | ProCook Group PLC (PROC:LON), 36.4 | 029 Group SE (Z29:ETR), 0 | 1895 Bancorp of Wisconsin Inc (BCOW:NYSE), 0 | 1895 Bancorp of Wisconsin Inc (BCOW:OTC), 0 | Coral Products plc (CRU:LON), 8.6 | Cordel Group PLC (CRDL:LON), 6.2 | Diaceutics Plc (DXRX:LON), 142 | Guardian Metal Resources PLC (GMET:LON), 158 | HemoGenyx Pharmaceuticals Plc (HEMO:LON), 636 | 10X Genomics Inc (TXG:NYSE), 0 | 10x Genomics Inc Class A (TXG:NAS), 0 | 123fahrschule SE (123F:ETR), 0 | Abingdon Health PLC (ABDX:LON), 6.5
- Published:
08 Jan 2025 -
Author:
Hybridan Team -
Pages:
2 -
Abingdon Health 8.00p £15.49m (ABDX.L)
The international lateral flow contract research and contract development and manufacturing organisation (CDMO), reports winning a £0.5m 12-month contract. Starting in March 2025, its recently acquired subsidiary, CS (Lifesciences) Ltd, will work with a major global diagnostics client on quality management systems and regulatory approvals. The CS subsidiary is a consultancy specialising in compliance requirement in international in vitro diagnostics and m ....